Randomized controlled trial of abductor muscle damage in relation to the surgical approach for primary total hip replacement: minimally invasive anterolateral versus standard transgluteal approach
Not Applicable
- Conditions
- M16.0M16.1Primary coxarthrosis, bilateralOther primary coxarthrosis
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 44
Inclusion Criteria
patients with primary hip arthritis,
unilateral total hip arthroplasty
Exclusion Criteria
incompliance,
patients with a heavy muscular disease,
patients with a heavy damage of the central or peripheral nervous system
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Preoperatively:<br>1. MRI to evaluate the soft tissue (cross sectional area, fatty atrophy, tendon defects, inflammation signs (fluid, bursitis, tendinitis)<br><br>3- Months follow-up<br>1. MRI - Evaluation of the soft tissue 3 months postoperatively<br><br>12- Months-follow-up<br>1. MRI - Evaluation of the soft tissue 12 months postoperatively
- Secondary Outcome Measures
Name Time Method Preoperatively<br>1. Abduction Test (to measure the hip abduction force)<br>2. Clinical investigation (age, weight (kg), sex, height (cm))<br>3. Clinical scores (Harris Hip, Oxf-12-Hip Score, WOMAC, Satisfaction, Pain)<br>4. Blood test (to evaluate normal values) <br><br>Postoperatively<br>1. Blood test (to measure muscle related enzymes for evaluation of muscle trauma)<br><br>3- Months follow-up<br>1. Clinical investigation (to objectify patients outcome)<br>2. Clinical scores (Harris Hip, Oxf-12-Hip Score, WOMAC, Satisfaction, Pain)<br>3. Abduction Test (to measure the hip abduction force)<br><br>12- Months follow-up<br>1. Clinical investigation (to objectify patients outcome)<br>2. Clinical scores (Harris Hip, Oxf-12-Hip Score, WOMAC, Satisfaction, Pain)<br>3. Abduction Test (to measure the hip abduction force)